Slum and Rural Health Initiative

Center for One Health and Zoonotic Diseases (COHAZD)

We are leading Africa’s One Health and Zoonotic Disease Control, Prevention and Digital Transformation

About the Center

The Center for One Health and Zoonotic Diseases is Africa’s forward command for predicting, preventing, and controlling diseases before they become disasters. We fuse science, surveillance, and digital innovation to stop outbreaks at their source , not after headlines break. From zoonotic disease intelligence to digital health systems, we are building Africa’s frontline defense for a safer, healthier, more resilient future.

01

Surveillance & Biosecurity

02

Community Advocacy & Partnership

03

Digital Management & Transformation

Key Focus Areas

06

Computational Analysis & Big Data Management

04

Interdisciplinary Research & Intervention

05

Policy Advocacy & Government Partnerships

February 20, 2026

LASSA FEVER: OUTBREAK, TRENDS, SYMPTOMS, PREVENTION, & DIAGNOSIS

Lassa fever is an acute viral haemorrhagic illness caused by the Lassa virus, first identified in Nigeria in 1969. It is endemic in West Africa, with Nigeria often recording the highest number of annual cases. Outbreaks occur most frequently between October and May, making the dry season a period of heightened risk.

The virus is primarily transmitted from infected rodents (Mastomys natalensis) to humans, and it continues to pose significant public health challenges due to environmental, social, and infrastructural factors.

Poor waste management, overcrowded housing, and improper food storage significantly increase risk.

Credit: NIAID

How Lassa Fever Spreads in Nigeria

1. Rodent-to-Human Transmission

The multimammate rat (Mastomys natalensis) serves as the natural reservoir for the virus. These rodents commonly inhabit and surround homes in many Nigerian communities. Humans become infected when they:

  • Touch food or household items contaminated with rodent urine or feaces
  • Inhale tiny particles from contaminated dust
  • Come into direct contact with rodents
Poor waste management, overcrowded housing, and improper food storage significantly increase risk.

2. Human-to-Human Transmission

Although less common, human-to-human transmission occurs through:

  •  Contact with the blood, vomit, urine, saliva, or other bodily fluids of an infected person
  • Poor infection control in healthcare settings
  • Caregiving without protective equipment

Current Outbreak Trends

In 2025, Nigeria recorded over 955 confirmed cases and 176 deaths, and recent outbreaks in 2026 have affected multiple states, with hundreds of confirmed cases and a significant number of deaths. The states most frequently impacted include:

  • Edo
  • Ondo
  • Bauchi
  • Taraba
  • Ebonyi
  • Plateau

These patterns underscore the continued endemicity of the disease and the need for sustained preventive action.

Symptoms: What to Look Out For

Lassa fever has an incubation period of 2 to 21 days, and early symptoms often resemble malaria, making diagnosis challenging without laboratory testing.

Early Symptoms

  • Persistent fever
  • Weakness and tiredness
  • Headache
  •  Sore throat
  • Muscle aches
  • Nausea or vomiting
  •  Chest or abdominal pain

Severe Symptoms

If untreated, the disease may progress to more severe conditions, including:

  • Facial swelling
  • Difficulty breathing
  • Bleeding from the mouth, gums, or nose
  •  Shock
  • Confusion
  • Seizures or coma

Most Vulnerable Groups

  • Pregnant women, especially in the third trimester
  • Children and the elderly
  • People with underlying health condition 

Many survivors also develop temporary or permanent hearing loss

Preventive Measures: How to Stay Safe

Because there is no approved vaccine yet, prevention remains the most powerful tool against Lassa fever. Key protective measures include:

1. Rodent Control at Home

  • Store food in tightly covered, rodent-proof containers
  • Keep homes and surroundings clean
  • Dispose of garbage far from living areas
  • Seal holes and cracks that allow rodent entry
  • Avoid drying food in open spaces where rodents may contaminate it

2. Community and Personal Prevention

  • Store food in tightly covered, rodent-proof containers
  • Avoid contact with rodent droppings
  • Store grains properly to prevent rodent infestation
  • Educate family and community members on symptoms and risks

3. Healthcare Setting Precautions

  • Use appropriate personal protective equipment (PPE)
  • Implement strict infection prevention and control (IPC) measures
  • Immediately isolate suspected or confirmed cases
  • Handle laboratory samples safely

These practices protect both health workers and the broader community

Diagnosis and Management

Prompt diagnosis saves lives. Because early symptoms mimic malaria and typhoid fever, any fever that does not respond to malaria treatment should raise suspicion.

Diagnosis

Lassa fever is confirmed through laboratory tests, including:

  • PCR tests
  • Antigen detection tests
  • Antibody tests

Treatment

There is no universal cure, but early treatment significantly improves survival.

  • Supportive care is the cornerstone: rehydration, fever control, monitoring vital organs
  • Early presentation to a designated treatment center is critical

Why Early Care Matters

Most Lassa fever deaths occur due to late presentation, as many people initially treat symptoms as malaria at home. Early hospital care increases the chances of recovery and reduces complications.

Partners & Funders

Our projects have been funded and supported by the following instiutions

Explore some of our impactful and life-changing programs

Canada-Africa MPox Project

We are leading Nigeria’s community research and advocacy component on Mpox (formerly ‘Monkeypox’) for the Canada-Africa Mpox project across several states in Nigeria

#EliminateTrachoma

The Trachoma project aims to assess the impact of an innovative health education programme on trachoma knowledge in IDP camps in Abuja, Nigeria. T

Covid-19 Project

The Youth COVID-19 Vaccination Advocacy program is SRHIN’s latest initiative aimed at increasing awareness and promoting vaccination in communities across Ethiopia.

We collaborate with universities, global health institutes, research laboratories, ministries of health, civil society organizations, and frontline health systems across Africa, Europe, and North America. These partnerships amplify our impact and expand the reach of our evidence-driven solutions.